China’s WuXi To Acquire U.S.-Based AppTec Laboratory Services
This article was originally published in PharmAsia News
Executive Summary
SHANGHAI - WuXi PharmaTech will acquire U.S.-based AppTec Laboratory Services, the Chinese pharma outsourcing company announced Jan. 3
You may also be interested in...
AstraZeneca Outsources Drug Discovery Research To BioDuro For Respiratory And Inflammation Indications
SHANGHAI - AstraZeneca is expanding its research collaboration with contract research organization BioDuro to cooperate on drug discovery research in respiratory and inflammation diseases in China, the two companies announced March 23
AstraZeneca Outsources Drug Discovery Research To BioDuro For Respiratory And Inflammation Indications
SHANGHAI - AstraZeneca is expanding its research collaboration with contract research organization BioDuro to cooperate on drug discovery research in respiratory and inflammation diseases in China, the two companies announced March 23
While Navigating Risks, WuXi To Benefit from Global Outsourcing
BEIJING - WuXi PharmaTech is positioning itself to ride the rising tides of global pharmaceutical outsourcing to strengthen its role as China's largest contract research organization, according to a WuXi executive and an independent analyst